We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIO icon
12376
PUT
Fortress Biotech
FBIO
$97.7M
$16K ﹤0.01%
1,307
-4,153
-76% -$61.5K
URG
12377
Ur-Energy
URG
$537M
$16K ﹤0.01%
14,780
-15,102
-51% -$20.2K
QNTM
12378
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$16K ﹤0.01%
+317
New +$19K
VEV
12379
DELISTED
Vicinity Motor Corp. Common Stock
VEV
$16K ﹤0.01%
+12,073
New +$21.1K
LMDXW
12380
DELISTED
LumiraDx Limited Warrant
LMDXW
$16K ﹤0.01%
18,170
-400
-2% -$346
YVR
12381
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$16K ﹤0.01%
+10,498
New +$21.1K
LABP
12382
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$16K ﹤0.01%
+2,112
New +$19.2K
SEAC
12383
PUT
DELISTED
Seachange International Inc
SEAC
$16K ﹤0.01%
1,295
-700
-35% -$12.2K
AXU
12384
DELISTED
Alexco Resource Corp
AXU
$16K ﹤0.01%
40,058
-96,464
-71% -$93.8K
AIHS icon
12385
Senmiao Technology Ltd
AIHS
$23.9M
$15K ﹤0.01%
1,477
+969
+191% +$11.2K
AKTX
12386
Akari Therapeutics
AKTX
$13.2M
$15K ﹤0.01%
+19
New +$16.8K
AMST icon
12387
Amesite
AMST
$6.37M
$15K ﹤0.01%
+2,685
New +$18.6K
CREX icon
12388
Creative Realities
CREX
$43M
$15K ﹤0.01%
+8,271
New +$17.3K
HIPO icon
12389
CALL
Hippo Holdings
HIPO
$872M
$15K ﹤0.01%
700
-4,192
-86% -$155K
JZXN icon
12390
Jiuzi Holdings
JZXN
$713K
$15K ﹤0.01%
2
KRKR
12391
36Kr Holdings
KRKR
$6.07M
$15K ﹤0.01%
744
-162
-18% -$3.01K
KXIN icon
12392
CALL
Kaixin Holdings
KXIN
$8.43M
0
LGMK
12393
PUT
DELISTED
LogicMark
LGMK
$15K ﹤0.01%
27
-85
-76% -$63.3K
LODE icon
12394
PUT
Comstock
LODE
$263M
$15K ﹤0.01%
2,380
+440
+23% +$4.39K
NCMI icon
12395
CALL
National CineMedia
NCMI
$269M
$15K ﹤0.01%
+1,620
New +$27.4K
QMCO icon
12396
CALL
Quantum Corp
QMCO
$1.03B
$15K ﹤0.01%
+520
New +$19.7K
SLDB icon
12397
CALL
Solid Biosciences
SLDB
$986M
$15K ﹤0.01%
1,647
+140
+9% +$1.46K
SDSTW
12398
Stardust Power Inc Warrant
SDSTW
$5.67M
$15K ﹤0.01%
82,786
-47,080
-36% -$13.5K
IVF
12399
INVO Fertility Inc
IVF
$1.74M
$15K ﹤0.01%
1
CFFSW
12400
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$15K ﹤0.01%
95,870
-185,714
-66% -$60.2K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.